Metal ion transporter SLC39A14-mediated ferroptosis and glycosylation modulate the tumor immune microenvironment: pan-cancer multi-omics exploration of therapeutic potential

In this study, we identified SLC39A14 as a dual regulator at the interface of ferroptosis and glycosylation, with significant impacts on tumor microenvironmental remodeling and therapeutic resistance. By leveraging multi-omics and single-cell transcriptomic data, we establish SLC39A14 as a promising prognostic biomarker and therapeutic target, particularly in brain and kidney cancers where ferroptosis modulation could offer novel clinical strategies.

Authors

Institutions

Publication Details

Journal
Cancer Cell International
Published
2025-10-21
DOI
https://doi.org/10.1186/s12935-025-04003-6
Citations
3
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
4.56

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metal ion transporter SLC39A14-mediated ferroptosis and glycosylation modulate the tumor immune microenvironment: pan-cancer multi-omics exploration of therapeutic potential

Kai‐Fu Chang, Chien‐Han Yuan, Shun‐Fa Yang, Chi-Jen Wu et al.
3 citations
Cancer Cell International
Ferroptosis and cancer prognosis
4.56
article

Metal ion transporter SLC39A14-mediated ferroptosis and glycosylation modulate the tumor immune microenvironment: pan-cancer multi-omics exploration of therapeutic potential

Kai‐Fu Chang, Chien‐Han Yuan, Shun‐Fa Yang, Chi-Jen Wu, Do Thi Minh Xuan, Ching‐Chung Ko, Yung‐Kuo Lee, Chih-Hsuan Chang, Chih‐Yang Wang, Damtew Solomon, Hung‐Yun Lin, Chung-Bao Hsieh, Sachin Kumar, Fitria Sari Wulandari, Yi-Chun Chiang, Hui-Ru Lin, Juan Lorell Ngadio
article en
3 citations

Abstract

In this study, we identified SLC39A14 as a dual regulator at the interface of ferroptosis and glycosylation, with significant impacts on tumor microenvironmental remodeling and therapeutic resistance. By leveraging multi-omics and single-cell transcriptomic data, we establish SLC39A14 as a promising prognostic biomarker and therapeutic target, particularly in brain and kidney cancers where ferroptosis modulation could offer novel clinical strategies.

Cancer Cell InternationalVol. 25(1)
Tri-Service General Hospital (TW), National Sun Yat-sen University (TW), Kaohsiung Medical University (TW), Taipei Medical University Hospital (TW), Albany College of Pharmacy and Health Sciences (US), Chung Shan Medical University Hospital (TW), Kaohsiung Armed Forces General Hospital (TW), Van Lang University (VN), Shoolini University (IN), Chi Mei Medical Center (TW), Indonesia International Institute for Life Sciences (ID), Wan Fang Hospital (TW), Taipei Medical University (TW), Chia Nan University of Pharmacy and Science (TW), National Defense Medical Center (TW), Chung Shan Medical University (TW)
Office of Research and Development, Ministry of Education, India, Taipei Medical University, Kaohsiung Armed Forces General Hospital, National Science and Technology Council, Office of Research and Development, Taipei Medical University
Openalex Percentile: Top 5%
Ferroptosis and cancer prognosis
4.56
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.